Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah… - JAMA …, 2021 - jamanetwork.com
Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes
from COVID-19. To our knowledge, no studies have established a beneficial role for anti–
COVID-19 interventions in this at-risk population. Convalescent plasma therapy may benefit
immunocompromised individuals with COVID-19, including those with hematologic cancers.
Objective To evaluate the association of convalescent plasma treatment with 30-day …
established hematologic cancers as a risk factor associated with particularly poor outcomes
from COVID-19. To our knowledge, no studies have established a beneficial role for anti–
COVID-19 interventions in this at-risk population. Convalescent plasma therapy may benefit
immunocompromised individuals with COVID-19, including those with hematologic cancers.
Objective To evaluate the association of convalescent plasma treatment with 30-day …